Diagnosis and treatment of social phobia

Journal of Practical Psychiatry and Behavioral Health

Volumn 2, Issue 2, 1996, Pages 94-104

  Schneier, Franklin R ^b   Juster, Harlan R ^c   Heimberg, Richard G ^c   Liebowitz, Michael R ^a  

^a Columbia University ^*

^b NEW YORK STATE PSYCHIATRIC INSTITUTE   (United States)

^c STATE UNIVERSITY OF NEW YORK   (United States)

Author keywords

Benzodiazepines; Beta blockers; Cognitive behavioral therapy; Diagnosis; Monoamine oxidase inhibitors; Selective serotonin reuptake inhibitors; Social phobia

Indexed keywords

EID: 0343231622     PISSN: 10765417     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (15)

1. American Psychiatric Association. Diagnostic and statistical manual of mental disorders, 4th edition. Washington, DC: American Psychiatric Association; 1994.
2. Kessler RC, McGonagle KA, Zhao A, et al. Lifetime and 12-month prevalence of DSM-III-R psychiatric disorders in the United States. Arch Gen Psychiatry 1994;51:8-19.
3. Stein MB, Walker JR, Forde DR: Setting diagnostic thresholds for social phobia: Considerations from a community survey of social anxiety. Am J Psychiatry 1994;151:408-12.
4. Liebowitz MR. Social phobia. Mod Probl Pharmacopsychiatry 1987;22:141-73.
5. Mattick RP, Clarke JC. Development and validation of measures of social phobia scrutiny fear and social interaction anxiety. Unpublished manuscript. 1989.
6. McNeil DW, Ries BJ, Turk CL. Behavioral assessment: Self-report, physiology and overt behavior. In: Heimberg RG, Liebowitz MR, Hope DA, Schneier FR, eds. Social phobia: Diagnosis, assessment and treatment. New York: Guilford Press; 1995:202-31.
7. Heimberg RG. Cognitive-behavioral treatment of social phobia in a group setting: A treatment manual, 2nd edition. Unpublished manuscript, 1991.
8. Heimberg RG, Juster HR. Cognitive-behavioral treatment: Literature review. In: Heimberg R, Liebowitz M, Hope D, Schneier F, eds. Social phobia: Diagnosis, assessment, and treatment. New York: Guilford Press; 1995:261-309.
9. Heimberg RG, Dodge CS, Hope, DA, et al. Cognitive-behavioral group treatment of social phobia: Comparison to a credible placebo control. Cognitive Therapy and Research 1990;14:1-23.
10. Heimberg RG, Salzman DG, Holt CS, Blendell KA. Cognitive-behavioral group treatment for social phobia: Effectiveness at five-year follow-up. Cognitive Therapy and Research 1993;17:325-39.
11. Heimberg RG, Juster HR, Brown EB, et al. Cognitive-behavioral versus pharmacological treatment of social phobia: Posttreatment and follow-up effects. Poster presented at the Association for the Advancement of Behavior Therapy, San Diego, CA: November, 1994.
12. Potts LS, Davidson JRT. Pharmacological treatments: Literature review. In: Heimberg RG, Liebowitz MR, Hope DA, Schneier FR, eds. Social phobia: Diagnosis, assessment and treatment. New York: Guilford Press; 1995:334-65.
13. Stein MB, Chartier MJ, Hazen AL, Kroft CDL, Chalc RA, Walker JR: An open-label clinical trial of paroxetine with a placebo-controlled discontinuation phase in patients with generalized social phobia. J Clin Psychopharmacol (in press).
14. Davidson JRT, Potts NLS, Richichi E, et al. Treatment of social phobia with clonazepam and placebo. J Clin Psychopharmacol 1993;13:423-9.
15. Liebowitz MR, Schneier FR, Campeas R, et al. Phenelzine vs. atenolol in social phobia: A placebo-controlled comparison. Arch Gen Psychiatry 1992;49:290-300.